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A general computational procedure for the modelling of intercalated DNA-ligand complexes has been de- 
veloped, and is used here to model intercalated complexes of the (+)-anti and (-)-anti enantiomers of 
benzo[a]pyrene diol-epoxide (BPDE) with cytosine-3’,5’-guanosine double-stranded DNA sequences 
(dCpG). Results are presented indicating differences between the behaviours of the two enantiomers which 
have implications for the understanding of the stereospecificity of DNA strand breakage by benzo[a]pyrene 
diol-epoxides. 
DNA damage Benzo[alpyrene Intercalation DNA 
Single-strand cleavage mechanism 
Molecular modelling 
1. INTRODUCTION 
Benzo[a]pyrene was identified as a potent car- 
cinogen as early as 1933 [l]. Following this, much 
effort was expended in attempting to determine 
structure-activity relationships for compounds of 
this type, until it was realised that the ultimate car- 
cinogens were more probably metabolites of the 
hydrocarbons [2,3], particularly dihydrodiol- 
epoxide derivatives where the epoxide ring is 
vicinal to a concavity in the edge of the hydrocar- 
bon plane, the so-called ‘bay region’ [4]. 
Of the four possible enantiomers of ben- 
zo[a]pyrene 7,8-diol-9,10-epoxide, metabolic 
activation involves predominantly the 7R,8S- 
diol-9S,lOR-epoxide (the (+)-anti form), with 
minor contributions from the 7S,8R,9R,lOS (the 
(-)-anti) and 7R$S,9R,lOS (the (-)-syn) forms 
(fig.1). The (+)-anti has by far the highest 
mutagenicity [5], and tumorigenicity [6] of the 
enantiomers. Interaction of (+)-anti-BPDE with 
DNA is known to result in the formation of stable 
covalent adducts (primarily with guanosine 
A 




Fig. 1. Stereoisomers of benzo[a]pyrene 7,8-diol-9, lo- 
epoxide. (a) (+)-anti, (b) (-)-anti, (c) (+ )-syn, (d) 
(- )-syn. 
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residues at the exocyclic N2 position) [7,8], alkali- 
labile adducts resulting in depurination [9- 111, 
and single-strand breaks at neutral pH [ 12,131. Re- 
cent results [ 141 have shown single-strand breakage 
to be significantly sequence specific, primarily oc- 
curring at pyrimidine-3 ’ ,5 ’ -guanine sites, and 
highly specific single-strand lesions leading to 
point mutations have been generated in vitro by 
anti-BPDE in the Ha-ras gene, leading to on- 
cogenic activation upon transfection [ 151. 
(iii) The resultant of the major inertial axes of the 
two base pairs was calculated, and the DNA coor- 
dinates from the previous step were rotated around 
the z axis so that this resultant major axis became 
aligned with the Cartesian x axis, thus defining the 
local x axis, and fixing the y axis as the mutual 
perpendicular of the x and z axes, such that the 
direction of positive increase gave a right-handed 
set. 
That the degree but not the pattern of site- 
specific cleavage is increased by hot alkali treat- 
ment of DNA exposed to anti-BPDE [14,16] sug- 
gests that the mechanism of single-strand breakage 
involves the formation of guanine N7-BPDE 
covalent adducts whose weakened glycosidic bonds 
lead to depurination, yielding apurinic sites which 
are labile to alkali cleavage [17]. 
Earlier molecular modelling studies [ 181 have in- 
vestigated the general interactions possible be- 
tween BPDE enantiomers and DNA in a 
non-covalent intercalated complex. Here, we ex- 
plore the specific interactions that may lead to for- 
mation of a labile guanine N7 covalent adduct, and 
the limitations imposed upon the formation of 
such an adduct by the stereochemistry of the 
BPDE ligand. 
2.2. Alignment of ligand 
(i) The coordinates of the ligand were translated 
so that the centroid of the atoms forming the inter- 
calating segment coincided with the centroid of the 
DNA atoms of the base pairs forming the inter- 
calation site; 
(ii) The least-squares plane of the atoms forming 
the intercalating segment of the ligand was 
calculated, and the coordinates transformed so 
that the normal to this plane lay parallel to the 
planes of the base pairs forming the intercalation 
site; 
(iii) The major inertial axis of the intercalating 
segment of the ligand was calculated, and the coor- 
dinates rotated around the z axis so that the major 
axis was aligned with the x axis (fig.2). 
‘t 
2. EXPERIMENTAL 
Coordinates for the intercalated double- 
stranded dCpG and all BPDE enantiomers derive 
from X-ray crystallographic studies of drug- 
dinucleotide intercalation complexes, and of 
BPDE stereoisomers [ 19-211. 
Coordinates of the initial intercalation com- 
plexes were generated by the following procedure. ‘t 
2.1. Generation of local DNA axes 
(i) The DNA coordinates were translated so that X 
the centroid of the atoms forming the base pairs 
lies at the origin of Cartesian space; 
(ii) The helix axis was calculated as the resultant * 
b 
of the normals to the least-squares planes of the 
two base pairs forming the intercalation site, and 
Fig.2. Initial intercalation geometry. (a) Local axes 
the coordinates of the DNA were rotated so that 
shown superimposed on DNA intercalation site, and (b) 
shown imposed on (+)-anti-BPDE. The initial 
the helix axis lay parallel to the Cartesian z axis, set- 
ting the planes of the base pairs parallel to the x-y 
plane; 
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intercalation geometry is achieved by alignment of the 
centroids (marked with a spot), in the orientation 
shown. 
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The position of the BPDE ligand relative to the 
DNA was thus defined with respect to this initial 
conformation by three parameters, u and v being 
respectively the components parallel to the x and y 
axes of the vector relating the centroid of the inter- 
calation base pairs to the centroid of the inter- 
calating segment of the ligand, and 8, the angle of 
rotation around the z axis between the major axis 
of the intercalation site base pairs, and the major 
axis of the intercalating segment of the ligand 
(fig.3). 
Intermolecular interaction energies were 
calculated using a conventional molecular 
mechanics force field incorporating electrostatic 
and Lennard-Jones terms. The non-bonded in- 
teraction energy between the two atoms i and j is 
given by: 
Eij = 
A B - -- 
r12 r6 
where rzj is the distance between the interacting 
pair of atoms, qi and qj are their point charges, and 
A and B are respectively the repulsive and attrac- 
tive components of the Lennard-Jones potential. 
The dielectric constant D is linearly dependent on 
rij. 
The values of the partial charges for the DNA 
are from [22], while those for the BPDE were 
calculated by the CND0/2 method. The values for 
the Lennard-Jones parameters for all atoms are 
from [23]. Hydrogen atoms are treated explicitly in 
both electrostatic and Lennard-Jones terms. 
This initial intercalation complex was used as the 
starting point for three procedures: 
Fig.3. Definition of intercalation variables. 
(1) Location of energy minima by rigid body 
docking with respect to u, v and 6’; 
(2) Scanning of the intercalation energy space as 
a function of u, v and 19; 
(3) Monitoring the distances between guanine N7 
atoms, and the reactive epoxide ring oxygen 0109 
of BPDE. 
(1) Location of energy minima 
The BPDE was positioned relative to the 
dinucleoside in the initial geometry defined above, 
with the parameters u and v initially zero. Rigid 
body energy minimisations were performed start- 
ing at eight different values of B at 45” intervals 
between 0 and 360”. Interaction energies and 
derivatives were calculated as described above and 
minimisations with respect to the parameters u, v 
and B were performed using a variable metric 
technique [24,25] and were run interactively on a 
VAX 11/750. 
(2) Energy scans 
The BPDE was positioned as described above, 
and the interaction energy of the BPDE and the 
DNA was calculated for values of u between - 2.5 
to +2.5 A, v between - 3.5 to + 3.5 A both in 
steps of 0.25 A, and values of 19 varying from 170 
to 370” in steps of 10”. 
(3) Distance scans 
The BPDE was positioned as described above, 
and the distance to the N7 atom of the guanine on 
the same side of the pyrene plane as the epoxide 
ring oxygen 0109 was calculated for values of u 
between -2.5 to +2.5 A, v between - 3.5 to 
+3.5 A both in steps of 0.25 A, and values of B 
varying from 170 to 370” in steps of 10”. 
3. RESULTS 
3.1. Location of energy minima 
Energy minima for the (+ )-anti and (- )-anti 
enantiomers located by the rigid body docking pro- 
cedure are given in table 1, along with the shortest 
guanine N7-BPDE epoxide oxygen distances 
possible at these minimum positions. Values of B 
between 180 and 360” correspond to the diol- 
epoxide grouping in the major groove. 
It is clear from these results that there are a 
range of minima of comparable energy, available 
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Table 1 
Intercalation energy minima for (+)-anti-BPDE (a) and 
( - )-anti-BPDE (b) 
&nter (kcal) u (A) v (A) 8 (“) DO-N (A)" 
(a) (+)-anti-BPDE 
- 69.7 - 1.001 - 0.571 315.6 3.00b 
- 68.6 -0.193 -0.584 319.3 2.46b 
-68.2 -0.104 -0.103 322.8 2.47b 
-65.9 0.002 0.03 1 202.5 5.67 
- 65.6 1.017 - 0.782 44.4 6.86 
-65.5 - 0.295 0.271 105.6 6.63 
- 64.4 0.552 0.096 210.3 5.92 
-62.1 - 2.505 0.824 131.1 5.51 
(b) (-)-anti-BPDE 
-71.5 1.393 -0.107 31.7 7.24 
-66.5 - 0.201 - 0.657 219.3 3.85 
-63.8 0.300 -0.099 328.9 5.09 
-61.3 -0.178 -1.334 247.8 5.22 
-61.0 1.887 1.717 12.1 5.49 
-60.8 1.316 -0.240 80.8 6.35 
- 59.3 - 1.495 0.188 83.6 6.70 
- 56.5 0.764 -0.139 270.6 6.34 
a This distance is defined between N7 of guanine and 
0109 of BPDE 
b These distances represent atoms within van der Waals 
contact 
for both enantiomers. This is in marked contrast 
with our observations for other intercalators such 
as substituted acridines and anthraquinones [26] 
which tend to have fewer and more clearly defined 
minimum energy positions. The lack of any signifi- 
cant difference in the energy minimum values ob- 
tained for the two BPDE enantiomers would 
suggest that both would be capable of forming 
favourable intercalation complexes with a 
C-3 ’ ,5 ’ -G double-stranded DNA sequence. Where 
they do differ most markedly however, is in the 
proximity of the reactive epoxide ring oxygen to 
the guanine N7 atom: the (-)-anti enantiomer 
cannot make a close contact at any of its minima, 
whereas the (+)-anti enantiomer has distances 
within van der Waals contact for its three lowest 
energy positions (fig.4). 
b 
Fig.4. Structure of potentially reactive interaction of 
( + )-anti-BPDE and dCpG. Stereo pairs of a complex 
between (+)-anti-BPDE and the dCpG duplex with a 
favourable interaction energy and a close proximity 
between the epoxide of BPDE and the N7 atom of 
guanine. This conformation was located by rigid body 
minimisation (see text), and corresponds to the second 
minimum in table la. (a) View along the local y axis, and 
(b) view along the local x axis. 
3.2. Energy and distance scans 
Largely as a result of the multiple minima 
located in the rigid body docking procedure, 
energy and epoxide-N7 distance scans were per- 
formed for both enantiomers. Contour maps of 
the interaction energy and the 3.0 A N7-epoxide 
distance in regions of interest for both enantiomers 
are shown in figs 5 and 6. The energy hypersur- 
faces revealed by these scans confirm the observa- 
tion from the rigid body minimisation, of a broad 
function with no clearly delimited global 
minimum, for both enantiomers. The superim- 
posed distance contours similarly confirm the 
availability of a large low-energy region of the 
hyperspace for the (+)-anti enantiomer, within 
which the guanine N7 and BPDE epoxide groups 
are capable of coming into close and probably 
reactive proximity particularly in the regions with 
280” 1 6’ 5 360”) while the ( -)-anti enantiomer 
shows only a very narrow coincidence of low 
energy and close contact, with the epoxide in the 
major groove, in the regions with 170” 1 B 5 190”. 
Fig.5. Contour plots of interaction energy as a function of U, v and B for ( + )-anti-BPDE. u is horizontal and v is 
vertical. The position (u,v) = (0,O) is marked with a cross. The circle superimposed on the sections is the 3.0 A contour 
of the distance, as a function of u,v and B, between the BPDE epoxide oxygen and the guanine N7 of the base pair 
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on the same side of the z = 0 plane. 
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Fig.6. Contour plots of interaction energy as a function of U,V and B for (- )-anti-BPDE. 
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4. DISCUSSION 
There is much evidence that the covalent ben- 
zo[a]pyrene-DNA complex has the benzo[a]pyrene 
moiety situated externally in the minor groove of 
the helix [27-291. Recent data are fully consistent 
with a classic intercalation model as the major 
form of initial recognition and interaction for the 
anti-diol-epoxides [30-331. It also appears likely 
that the mechanism of mutagenic single-strand 
breakage involves depurination subsequent o the 
formation of an N7-attached covalent adduct. The 
present study shows that intercalated BPDE com- 
plexes of low energy can be modelled, which allow 
for a close contact (< 2.5 A) of the reactive epoxide 
oxygen with the guanine N7, which would be likely 
to proceed to formation of an N7 covalent adduct. 
The marked difference between the (+)-anti and 
(-)-anti enantiomers in their ability to achieve a 
potentially reactive N7-epoxide contact leads us to 
predict that the (-)-anti enantiomer would have a 
consequent lower activity in generating single- 
strand breaks, which appear to be favoured at 
pyrimidine-3’,5’-guanosine sites, such as the 
cytosine-3 ’ ,5 ’ -guanosine sequence we have 
employed in this study. We are currently studying 
the (+)- and ( -)-syn enantiomers of BPDE in a 
similar manner. 
The experimentally determined preference for 
pyrimidine-3 ’ ,5 ‘-guanosine sites for BPDE- 
induced strand breaks may be rationalised in terms 
of earlier findings on the sequence preferences 
shown by non-covalent-binding intercalative drugs 
and mutagens. NMR studies [34] and X-ray 
crystallographic analyses (e.g. [20,35]) show such a 
preference. These have been reinforced by energy 
calculations [36], which indicate that increasing the 
base-pair to base-pair separation from 3.4 to 6.8 A 
in order to allow intercalation is energetically more 
favourable for a pyrimidine-3 ’ ,5 ’ -purine sequence 
than for other sequences. 
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